Poster Session I. - T: Cardiovascular Medicine and Research
Dr. Bernáth-Nagy Dominika
PWJ6KL
Semmelweis University
+36203853668
bernath.nagy.dominika@semmelweis.hu
Isolation and Quantification of Circulating Extracellular Vesicles in Myocardial Homeostasis, Strain, and Ischemia States
Dominika Bernáth-Nagy1, Jona Benjamin Krohn2, Gabriel Jakob Trauner3, Melek Sükran Kalinyaprak3, Florian Sicklinger2, Niklas Hartmann3, Daniela Pimonov3, Pál Ábrahám4, Florian Leuschner2, Constanze Schmidt3, Felix Wiedmann3, Maren Harden3, Norbert Frey2, Evangelos Giannitsis3
1: Heart and Vascular Centre of Semmelweis University, Budapest, Hungary; Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany
2: Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany; German Centre for Cardiovascular Research (DZHK) Partner Site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany
3: Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany
4: Heart and Vascular Centre of Semmelweis University, Budapest, Hungary
Poszter
Poster Session I. - T: Cardiovascular Medicine and Research
English
Cardiovascular Medicine and Research
Extracellular vesicles (EV) are membranous nanoparticles that are key elements of intercellular communication. EVs are released by a multitude of cell types and bear the potential to provide information on their cell of origin and their state. It has been shown that in vitro hypoxic conditioning triggers EV release by intact cardiomyocytes.
Translation of these in vitro findings to disease pathophysiologies in acute clinical settings is challenging. The aim of this study is the quantification of circulating EVs in different cardiovascular diseases (CVD) in patients, small- and large animal models.
Patients presenting to the Chest Pain Unit were recruited prospectively. Patients with non-ST elevation myocardial infarction (NSTEMI) (n=18) and with supraventricular tachyarrhythmia (SVT) (n=39) were identified and compared to a cohort of healthy volunteers (n=27). Peripheral blood was drawn, EVs were isolated and quantified with nanoparticle tracking analysis (NTA). The results of the NSTEMI patient cohort were validated in a murine model of minimal invasive myocardial infarction, whereas as a validation of the results of the SVT patient cohort a large animal model of induced SVT was utilized.
Quantification of circulating EVs in patients suffering NSTEMI revealed a ~3-fold increase (p<0.0001), and SVT-induced myocardial strain a ~2-fold increase (p<0.0001) in systemic EV release compared to control states. In the murine model of myocardial ischemia, NTA revealed a ~3-fold increase in total circulating EV release four hours after anterior wall infarction compared to sham controls bordering statistical significance (p=0.07). In the swine model of induced SVT, EVs isolated from plasma samples of specimen suffering from sustained atrial fibrillation showed a ~3-fold increase compared to control states (p<0.001).
In this extensive study on systemic EV release in patients as well as in small and large animal models of myocardial ischemia and strain, a quantitative increase in circulating EV release is demonstrated. These findings add to a growing body of evidence underlining the diagnostic value of circulatory EVs in CVDs and particularly its potential as an early-stage marker of myocardial strain or injury.
This study was funded by the University Hospital Heidelberg and Roche Diagnostics through an Investigator Initiated Trial contract.
Semmelweis University
Pál Ábrahám; Evangelos Giannitsis
I do not give consent to the publication of my abstract on the website of the congress.
in doctoral studies before complex exam (PhD)
Szabad
elfogadva
poszter
nem rendelkezett róla
9064
17:06
17:12